Selection of patients with portal hypertension and cirrhosis who will benefit from beta-blockers: Still a current challenge

J Hepatol. 2024 Jan;80(1):e34-e35. doi: 10.1016/j.jhep.2023.05.048. Epub 2023 Jun 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists* / therapeutic use
  • Fibrosis
  • Humans
  • Hypertension, Portal* / complications
  • Hypertension, Portal* / drug therapy
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / drug therapy
  • Patient Selection

Substances

  • Adrenergic beta-Antagonists